2002 - 2018

• Identified platelets as diagnostics

• Selective protein sequestration

• Protein cargo reflects disease evolution

• Protein cargo can monitor therapy effectiveness

Why it matters: Platelets represent a novel and clinically useful analyte, providing non-invasive, precise molecular insights into disease biology.

2019 - 2023

• Built ClariaIQ™ platform

• Assays correlate with disease

• Patent portfolio established

Why it matters: Established tools & IP for precision diagnostics.

2023 - PRESENT

• Prostate & breast cancer HeLP™ tests

• Multi-cancer Screening HeLP™ Test

• Pipeline: pancreatic cancer, Alzheimer’s

Why it matters: Detect earlier. Treat Smarter. Save Lives.